Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BJ-005 |
Trade Name | |
Synonyms | BJ 005|BJ005 |
Drug Descriptions |
BJ-005 is a fusion protein comprising an anti-PD-L1 (CD274) antibody linked to the extracellular domain of Tgfbr2, which may decrease TGFbeta- and PD-L1-mediated immunosuppression, leading to increased antitumor immune response and reduced tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 121 |
CAS Registry Number | NA |
NCIT ID | C185426 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BJ-005 | BJ-005 | 0 | 1 |